18.06.2010 • NewsChemturareorganizationbankruptcy

Chemtura Files for Plan of Reorganization

Bankrupt U.S. chemicals maker Chemtura filed for a plan of reorganization with a U.S. court that would pave the way for the company to emerge from bankruptcy protection.

The plan, filed late on Thursday, is supported by the company's unsecured creditors and bondholders and requires the bankruptcy court's approval to become effective. Chemtura said the plan has the potential to satisfy all creditors' claims in full, as well as offering value to equity holders. It said in a statement that it expects to remain on track to emerge from Chapter 11 protection in the coming months.

Once the reorganization plans become effective, new Chemtura will issue up to 100 million shares of common stock to its debtors, court documents show. The company would then aim to list the New Common Stock on a national securities exchange, with the initial goal of listing on the New York Stock Exchange or Nasdaq by the effective date, as per the filing.

If the plan is approved by the court, then the company's new board will consist of nine directors, Chemtura said in the filing. Chemtura, with 2009 sales of about $2.5 billion, was hit by reduced demand and filed for bankruptcy protection last year, listing assets in excess of $3 billion.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.